Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction

Study Questions:

Do renin-angiotensin (RAS-I) antagonists impact mortality in patients with heart failure and preserved ejection fraction (HFPEF)?